Cleveland Clinic Journal of Medicine: 78 (11 suppl 2)

November 01, 2011; Volume 78,Issue 11 suppl 2

Progressive Multifocal Leukoencephalopathy in the Biologic ERA: Implications for Practice

You have access
Introduction
Leonard Calabrese, DO
Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S2; DOI: https://doi.org/10.3949/ccjm.78.s2.01
You have access
History and current concepts in the pathogenesis of PML
Eugene O. Major, PhD
Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S3-S7; DOI: https://doi.org/10.3949/ccjm.78.s2.02
You have access
The clinical features of PML
Joseph R. Berger, MD
Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S8-S12; DOI: https://doi.org/10.3949/ccjm.78.s2.03
You have access
Pharmacovigilance and PML in the oncology setting
Charles L. Bennett, MD, PhD, MPP
Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S13-S17; DOI: https://doi.org/10.3949/ccjm.78.s2.04
You have access
Multiple sclerosis, natalizumab, and PML: Helping patients decide
Richard A. Rudick, MD
Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S18-S23; DOI: https://doi.org/10.3949/ccjm.78.s2.05
You have access
HIV-associated PML: Changing epidemiology and clinical approach
David M. Simpson, MD, FRCP, FAAN
Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S24-S27; DOI: https://doi.org/10.3949/ccjm.78.s2.06
You have access
PML and rheumatology: The contribution of disease and drugs
Eamonn S. Molloy, MD, MS, MRCPI
Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S28-S32; DOI: https://doi.org/10.3949/ccjm.78.s2.07
You have access
Advances in the management of PML: Focus on natalizumab
Robert Fox, MD
Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S33-S37; DOI: https://doi.org/10.3949/ccjm.78.s2.08
You have access
A rational approach to PML for the clinician
Leonard Calabrese, DO
Cleveland Clinic Journal of Medicine November 2011, 78 (11 suppl 2) S38-S41; DOI: https://doi.org/10.3949/ccjm.78.s2.09

Main menu

User menu

Search

Table of Contents

Progressive Multifocal Leukoencephalopathy in the Biologic ERA: Implications for Practice

In this issue

Navigate

Authors & Reviewers